PROTAGONIST THERAPEUTICS INC (PTGX)
US74366E1029 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 170.85M | -78.95M | -127.39M | -125.55M | -66.15M | |||
| Depreciation Amortization | 955.00K | 977.00K | 1.03M | 810.00K | 790.00K | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | N/A | 1.44M | |||
| Change In Working Capital | 28.65M | -19.51M | -7.77M | -3.31M | -19.02M | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 440.00K | |||
| Other non cash items | 29.83M | 27.25M | 25.99M | 20.19M | 10.46M | |||
| OPERATING CASH FLOW | 230.29M | -70.24M | -108.14M | -107.87M | -72.48M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.06M | -609.00K | -800.00K | -1.10M | -470.00K | |||
| Other Investing Activity | -350.98M | -38.65M | 92.26M | -14.76M | -90.49M | |||
| INVESTING CASH FLOW | -352.05M | -39.26M | 91.47M | -15.86M | -90.97M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | N/A | -10.52M | |||
| Stock Issued/Repurchased | 22.95M | 171.25M | 19.00M | 130.11M | 258.16M | |||
| Other Financing Activity | -599.00K | -769.00K | -160.00K | -190.00K | -10.00K | |||
| FINANCING CASH FLOW | 22.35M | 170.48M | 18.84M | 129.92M | 247.63M | |||
| Exchange Rate Effect | N/A | 0.00 | -90.00K | -130.00K | 180.00K | |||
| CHANGE IN CASH | -99.40M | 60.98M | 2.08M | 6.06M | 84.36M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 230.29M | -70.24M | -108.14M | -107.87M | -72.48M | |||
| Capital Expenditure | -1.06M | -609.00K | -800.00K | -1.10M | -470.00K | |||
| FREE CASH FLOW | 229.23M | -70.84M | -108.94M | -108.97M | -72.95M | |||
All data in USD